Evidence map›Paper›PMID 39192019›Full record

ArticleArchives of toxicology2024

Toxicokinetics, in vivo metabolic profiling and tissue distribution of chlorfenapyr in mice.

Shunjie Zhang, Xin Wang, Xia Yang, Ziyang Ma, Peng Liu, Shiyuan Tang, Min Zhao, Haijun Chen, Qiang Qiu, Minghai Tang and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of toxicology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Shunjie ZhangDepartment of Emergency Medicine, Institute of Disaster Medicine, Institute of Emergency Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China.
Xin WangDepartment of Emergency Medicine, Institute of Disaster Medicine, Institute of Emergency Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China.
Xia YangDepartment of Emergency Medicine, Institute of Disaster Medicine, Institute of Emergency Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China.
Ziyang MaDepartment of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
Peng LiuDepartment of Emergency Medicine, Institute of Disaster Medicine, Institute of Emergency Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China.
Shiyuan TangDepartment of Emergency Medicine, Institute of Disaster Medicine, Institute of Emergency Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China.
Min ZhaoDepartment of Emergency Medicine, Institute of Disaster Medicine, Institute of Emergency Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China.
Haijun ChenSchool of Mechanical Engineering, Sichuan University, Chengdu, 610065, China.
Qiang QiuDepartment of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
Minghai TangDepartment of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China. tangminghai1982@126.com.
Aihua PengDepartment of Emergency Medicine, Institute of Disaster Medicine, Institute of Emergency Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China. peng_aihua@163.com.ORCID 0009-0003-3912-5185
Yu CaoDepartment of Emergency Medicine, Institute of Disaster Medicine, Institute of Emergency Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China.

Funding

Chengdu Technology Support Program 2022-YF09-00021-SNChongqing Key Laboratory of Emergency Medicine open project 2023KFKT05Sichuan Province Science and Technology Support Program 2023YFS0184the Fundamental Research Funds for the Central Universities 2023SCU12085the National Natural Science Foundation of China 82174077the Natural Science Foundation of Sichuan Province 2022NSFSC1292the Science and Technology Project of Xinjiang Production and Construction Corps 2022AB020
6 · The paper itself

Abstract

Chlorfenapyr is a novel broad-spectrum insecticide derived from natural pyrrole derivatives produced by Streptomyces spp. It acts as a pro-insecticide and is metabolically converted to the active metabolite, tralopyril. Chlorfenapyr poisoning is known for its delayed neurological symptoms and high mortality. Unfortunately, information on the toxicokinetics, metabolism and tissue distribution of chlorfenapyr and tralopyril is still lacking. In this study, the metabolic profile, toxicokinetics and tissue distribution of chlorfenapyr and tralopyril after oral administration at a toxic dose in mice were investigated. Twenty metabolites were identified in plasma, urine and feces, which were mainly formed by dealkylation, oxidative dechlorination and reductive dechlorination. Toxicokinetic results showed that chlorfenapyr was rapidly converted to tralopyril after administration, and the in vivo half-life (t

Indexed as

InsecticidesPyrethrinsToxicokineticsAdministration, OralAnimalsArea Under CurveFecesHalf-LifeMaleMiceTissue DistributionchlorfenapyrInsecticidesPyrethrinsChlorfenapyrMetabolismTissue distributionToxicokineticsTralopyril

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.